Racial and geographic disparities in adherence and discontinuation to adjuvant endocrine therapy in Texas Medicaid-insured patients with breast cancer Albert J. FariasWen-Hsing WuXianglin L. Du Original Paper 20 June 2018 Article: 113
Simultaneous PET/MRI in assessing the response to chemo/radiotherapy in head and neck carcinoma: initial experience Valeria RomeoBrigida IorioMario Covello Short Communication 19 June 2018 Article: 112
Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival Michela RobertoAndrea BotticelliPaolo Marchetti Original Paper 19 June 2018 Article: 111
Generalizability of clinical trials of advanced melanoma in the real-world, population-based setting Davis SamGillian GreshamWinson Y. Cheung Original Paper 18 June 2018 Article: 110
Clinical outcomes of African American patients with advanced or metastatic non-small cell lung cancer on Nivolumab in a single community-based cancer center Andrew C. TiuRashmika PotdarClaudia Dourado Original Paper 18 June 2018 Article: 109
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study Koji NishimotoMasato KarayamaTakafumi Suda Original Paper 16 June 2018 Article: 108
Discontinuation of hormone therapy for elderly breast cancer patients after hypofractionated whole-breast radiotherapy Michela DispinzieriEliana La RoccaMaria Carmen De Santis Original Paper 16 June 2018 Article: 107
ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer Matthias VillalobosPiotr CzapiewskiMichael Thomas Original Paper 15 June 2018 Article: 106
α-Viniferin activates autophagic apoptosis and cell death by reducing glucocorticoid receptor expression in castration-resistant prostate cancer cells Kejun ChengXi LiuDan-Feng Xu Original Paper 15 June 2018 Article: 105
Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma Yuji KonishiFutoshi KawamataAkinobu Taketomi Original Paper 11 June 2018 Article: 104
MGMT promoter methylation is not correlated with integrin expression in malignant gliomas: clarifying recent clinical trial results Oliver SchnellValerie AlbrechtChristian Schichor Original Paper 07 June 2018 Article: 103
Clinical and Histopathologic Correlates and Management Strategies for Inflammatory Myofibroblastic tumor of the lung. A case series and review of the literature Ala Eddin S. SagarCarlos A. JimenezVickie R. Shannon Review Article 04 June 2018 Article: 102
Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping George PapaxoinisVassiliki KotoulaGeorge Fountzilas Original Paper 31 May 2018 Article: 101
A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer Kei SaitoHiroyuki IsayamaKazuhiko Koike Original Paper 30 May 2018 Article: 100
Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors Tomonori NakazatoNoriyoshi IriyamaTatsuya Kawaguchi Original Paper 30 May 2018 Article: 99
Is there a role for immunotherapy in malignant pleural mesothelioma? Alfredo TartaroneRosa LeroseMichele Aieta Review Article 29 May 2018 Article: 98
Hyaluronic acid and hyaluronidase as possible novel urine biomarkers for the diagnosis of prostate cancer Ioannis SkarmoutsosAthanasios SkarmoutsosConstantinos Constantinides Original Paper 25 May 2018 Article: 97
